Liu Jiyan, Jiang Tingting, Jiang Feng, Xu Dandan, Wei Liliang, Wang Chong, Chen Zhongliang, Zhang Xing, Li Jicheng
College of Life and Environmental Sciences, Hangzhou Normal University Hangzhou, P. R. China.
Institute of Cell Biology, Zhejiang University Hangzhou, P. R. China.
Int J Clin Exp Med. 2015 Feb 15;8(2):2077-85. eCollection 2015.
A major challenge in pulmonary tuberculosis (TB) control is early and accurate diagnosis of sputum smear negative pulmonary TB (SSN-PTB). The patients with SSN-PTB have to wait for a longer period of time before receiving proper treatment than sputum smear positive pulmonary TB (SSP-PTB) patients due to delay in diagnosis. The purpose of this study is to discover potential serum protein biomarkers for SSN-PTB. Surface-enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) combined with weak cation exchange (WCX) magnetic beads was used to screen serum samples from SSN-PTB patients (N = 66), SSP-PTB patients (N = 49), and healthy volunteers (N = 80). The serum protein profiles were analyzed with Biomarker Wizard system. A classification model was established using Biomarker Pattern Software (BPS). Fifty-eight protein peaks were identified to exhibit significant differences between SSN-PTB, SSP-PTB and healthy control groups (P < 0.05), among which 6 peaks were found to be down-regulated, while 10 peaks were up-regulated gradually in the healthy control, SSN-PTB, and SSP-PTB groups. Twenty-three discriminating m/z peaks were detected between SSN-PTB patients and healthy controls (P < 0.01, Fold ≥ 1.5). The classification tree combined with three protein peaks (2747.0, 4480.0, and 9410.1 Da) could distinguish SSN-PTB patients from healthy controls with a sensitivity of 83.33% and a specificity of 82.50%. Early diagnosis of SSN-PTB disease is critical in order to reduce morbidity and mortality associated with TB. The study will help to clarify the role of differential proteins in the pathogenesis of TB.
肺结核(TB)控制中的一个主要挑战是对痰涂片阴性肺结核(SSN-PTB)进行早期准确诊断。由于诊断延迟,与痰涂片阳性肺结核(SSP-PTB)患者相比,SSN-PTB患者在接受适当治疗前必须等待更长时间。本研究的目的是发现SSN-PTB潜在的血清蛋白生物标志物。采用表面增强激光解吸/电离飞行时间质谱(SELDI-TOF MS)结合弱阳离子交换(WCX)磁珠技术,对66例SSN-PTB患者、49例SSP-PTB患者和80例健康志愿者的血清样本进行筛选。用Biomarker Wizard系统分析血清蛋白谱。使用Biomarker Pattern Software(BPS)建立分类模型。鉴定出58个蛋白峰在SSN-PTB、SSP-PTB和健康对照组之间存在显著差异(P<0.05),其中6个峰下调,而在健康对照、SSN-PTB和SSP-PTB组中10个峰逐渐上调。在SSN-PTB患者和健康对照之间检测到23个有鉴别意义的m/z峰(P<0.01,倍数≥1.5)。结合三个蛋白峰(2747.0、4480.0和9410.1 Da)的分类树能够以83.33%的灵敏度和82.50%的特异性区分SSN-PTB患者和健康对照。SSN-PTB疾病的早期诊断对于降低与结核病相关的发病率和死亡率至关重要。该研究将有助于阐明差异蛋白在结核病发病机制中的作用。